Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 4
1999 2
2000 5
2001 15
2002 17
2003 8
2004 16
2005 16
2006 14
2007 14
2008 14
2009 10
2010 6
2011 4
2012 8
2013 5
2014 1
2018 2
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11718433

157 results
Results by year
Filters applied: . Clear all
Page 1
Role of alendronate and risedronate in preventing and treating osteoporosis.
Peters ML, Leonard M, Licata AA. Peters ML, et al. Cleve Clin J Med. 2001 Nov;68(11):945-51. doi: 10.3949/ccjm.68.11.945. Cleve Clin J Med. 2001. PMID: 11718433 Free article. Review.
Risedronate: a new oral bisphosphonate.
Umland EM, Boyce EG. Umland EM, et al. Clin Ther. 2001 Sep;23(9):1409-21. doi: 10.1016/s0149-2918(01)80116-8. Clin Ther. 2001. PMID: 11589256 Review.
Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.
Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, Kagan R, Chen E, Petruschke RA, Thompson DE, de Papp AE; Fosamax Actonel Comparison Trial Investigators. Rosen CJ, et al. J Bone Miner Res. 2005 Jan;20(1):141-51. doi: 10.1359/JBMR.040920. Epub 2004 Sep 29. J Bone Miner Res. 2005. PMID: 15619680 Free article. Clinical Trial.
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J, Takeda T, Sato Y. Iwamoto J, et al. Curr Med Res Opin. 2006 May;22(5):919-28. doi: 10.1185/030079906X100276. Curr Med Res Opin. 2006. PMID: 16709313 Review.
Bisphosphonates for osteoporosis.
[No authors listed] [No authors listed] Drug Ther Bull. 2001 Sep;39(9):68-72. doi: 10.1136/dtb.2001.39968. Drug Ther Bull. 2001. PMID: 11586803 Review.
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis.
Sebba AI, Bonnick SL, Kagan R, Thompson DE, Skalky CS, Chen E, de Papp AE; Fosamax Actonel Comparison Trial investigators. Sebba AI, et al. Curr Med Res Opin. 2004 Dec;20(12):2031-41. doi: 10.1185/030079904x16768. Curr Med Res Opin. 2004. PMID: 15706659 Clinical Trial.
Gastroenterologists and choosing the right bisphosphonate.
Leder BZ, Kronenberg HM. Leder BZ, et al. Gastroenterology. 2000 Sep;119(3):866-9. doi: 10.1053/gast.2000.17841. Gastroenterology. 2000. PMID: 10982780 Review. No abstract available.
Bisphosphonates.
Diez-Perez A. Diez-Perez A. Maturitas. 2002 Aug 30;43 Suppl 1:S19-26. doi: 10.1016/s0378-5122(02)00145-7. Maturitas. 2002. PMID: 12361885 Review. No abstract available.
157 results
Jump to page
Feedback